[go: up one dir, main page]

UA105903C2 - Похідні дибензотіазепіну та їх застосування - Google Patents

Похідні дибензотіазепіну та їх застосування

Info

Publication number
UA105903C2
UA105903C2 UAA201015001A UAA201015001A UA105903C2 UA 105903 C2 UA105903 C2 UA 105903C2 UA A201015001 A UAA201015001 A UA A201015001A UA A201015001 A UAA201015001 A UA A201015001A UA 105903 C2 UA105903 C2 UA 105903C2
Authority
UA
Ukraine
Prior art keywords
disorder
compounds
dibenzothiazepine derivatives
dibenzothiazepine
derivatives
Prior art date
Application number
UAA201015001A
Other languages
English (en)
Russian (ru)
Inventor
Дін Браун
Джеймс Р. Дамевуд
Філ Едвардс
Джеймс Гульсізер
Джеймс Кампбелл Муір
Джр. М. Едвард Піерсон
Ашоккумар Біккаппа Шенві
Стівен Весоловскі
Ден Відзовскі
Майкл Вуд
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41431860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA105903(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Астразенека Аб filed Critical Астразенека Аб
Publication of UA105903C2 publication Critical patent/UA105903C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Сполуки формули І, де Ζ визначено в описі, їх фармацевтично прийнятні солі, композиції, що містять їх, і способи лікування зазначеними сполуками біполярного розладу, тривожного розладу, розладу настрою або шизофренії, або іншого психічного розладу.
UAA201015001A 2008-06-20 2009-06-18 Похідні дибензотіазепіну та їх застосування UA105903C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7441708P 2008-06-20 2008-06-20
PCT/SE2009/050763 WO2009154563A1 (en) 2008-06-20 2009-06-18 Dibenzothiazepine derivatives and use thereof

Publications (1)

Publication Number Publication Date
UA105903C2 true UA105903C2 (uk) 2014-07-10

Family

ID=41431860

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201015001A UA105903C2 (uk) 2008-06-20 2009-06-18 Похідні дибензотіазепіну та їх застосування

Country Status (37)

Country Link
US (3) US20110160184A1 (uk)
EP (1) EP2307389B1 (uk)
JP (2) JP5468068B2 (uk)
KR (1) KR20110019781A (uk)
CN (1) CN102131791B (uk)
AR (1) AR072200A1 (uk)
AU (1) AU2009260905B2 (uk)
BR (1) BRPI0914231A2 (uk)
CA (1) CA2728675A1 (uk)
CL (1) CL2010001471A1 (uk)
CR (1) CR11860A (uk)
CU (1) CU23884B1 (uk)
CY (1) CY1113845T1 (uk)
DK (1) DK2307389T3 (uk)
DO (1) DOP2010000393A (uk)
EA (1) EA201001889A1 (uk)
EC (1) ECSP10010698A (uk)
ES (1) ES2402084T3 (uk)
HN (1) HN2010002683A (uk)
HR (1) HRP20130234T1 (uk)
IL (2) IL210081A (uk)
ME (1) ME01516B (uk)
MX (1) MX2010014203A (uk)
MY (1) MY157518A (uk)
NI (1) NI201000224A (uk)
NZ (1) NZ590616A (uk)
PE (1) PE20110029A1 (uk)
PL (1) PL2307389T3 (uk)
PT (1) PT2307389E (uk)
RS (1) RS52703B (uk)
SI (1) SI2307389T1 (uk)
SV (1) SV2010003769A (uk)
TW (1) TWI488854B (uk)
UA (1) UA105903C2 (uk)
UY (1) UY31919A (uk)
WO (1) WO2009154563A1 (uk)
ZA (1) ZA201100488B (uk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488854B (zh) * 2008-06-20 2015-06-21 Astrazeneca Ab 二苯并噻氮呯衍生物及其用途
CN105981027A (zh) * 2013-08-12 2016-09-28 哥莱菲特软件公司 安全认证并切换至加密域
CN103524455A (zh) * 2013-10-30 2014-01-22 苏州敬业医药化工有限公司 一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法
EP3072320A4 (en) 2013-11-21 2017-05-24 Graphite Software Corporation Managed domains for remote content and configuration control on mobile information devices
CN104447615A (zh) * 2014-02-28 2015-03-25 广东东阳光药业有限公司 喹硫平中间体的制备方法
CN120981447A (zh) * 2023-03-08 2025-11-18 法兰克福大学 Slack激活化合物及其医学用途
EP4428132A1 (en) * 2023-03-08 2024-09-11 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294355A (uk)
NL293201A (uk)
DE1620703B2 (de) * 1960-08-16 1976-11-25 Ausscheidung aus: 12 80 879 Dr. A. Wander AG, Bern 11-basisch substituierte dibenzo eckige klammer auf b,f eckige klammer zu-eckige klammer auf 1,4 eckige klammer zu-thiazepine
CH422793A (de) 1961-07-20 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine
DE1470416A1 (de) 1962-05-25 1969-05-14 Wander Ag Dr A Verfahren zur Herstellung ll-basisch substituierter 5 H-Dibenzo[b,e],[1,4] diazepine
CH476753A (de) 1962-06-08 1969-08-15 Wander Ag Dr A Verfahren zur Herstellung von 11-basisch substituierter Dibenzo(b,f)(1,4)thiazepine
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
BE632120A (uk) 1963-05-09
US3884920A (en) * 1967-07-14 1975-05-20 Sandoz Ag 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines
US3908010A (en) * 1967-03-22 1975-09-23 Wander Ag Dr A Basically substituted heterocycles as anti-emetics
US3683034A (en) * 1963-09-27 1972-08-08 Upjohn Co Process for the preparation of substituted hydroquinones
US3412193A (en) * 1965-12-13 1968-11-19 American Cyanamid Co 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility
AT278805B (de) * 1966-01-17 1970-02-10 American Cyanamid Co Verfahren zur herstellung von oxazepinen und thiazepinen
NL6715650A (uk) 1966-12-16 1968-06-17
US3852446A (en) * 1967-03-13 1974-12-03 Sandoz Ag Organic compounds in treatment of psychotic disturbances
US3758479A (en) * 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
CH569730A5 (uk) * 1972-04-04 1975-11-28 Wander Ag Dr A
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
JPH04211071A (ja) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd 多環式化合物
JPH0565257A (ja) 1991-07-05 1993-03-19 Hokuriku Seiyaku Co Ltd 多環式化合物及びその用途
US5661184A (en) * 1994-08-12 1997-08-26 Eli Lilly And Company Psychiatric agents
SK282366B6 (sk) 1994-08-24 2002-01-07 Astra Aktiebolag Spiro-azabicyklická zlúčenina, farmaceutický prípravok s jej obsahom, spôsob prípravy, medziprodukty tohto spôsobu a jej použitie v medicíne
US5602121A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
US6342488B1 (en) * 1998-08-18 2002-01-29 Sepracor, Inc. Phosphonorisperidone and sulforisperidone compositions and methods
SE9900100D0 (sv) 1999-01-15 1999-01-15 Astra Ab New compounds
JP2003505505A (ja) 1999-07-28 2003-02-12 オスヴァルト・ヴィス 運動時の酸素消費を低下するための製剤
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
SE0002729D0 (sv) 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
WO2002060870A2 (en) 2000-11-17 2002-08-08 Adolor Corporation Delta agonist analgesics
IL139975A0 (en) 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
AR035974A1 (es) 2001-05-18 2004-07-28 Astrazeneca Ab Derivados de diarilmetil piperazina, procesos para su preparacion, uso de estos derivados para la elaboracion de medicamentos y composicion farmaceutica
IL158735A0 (en) 2001-06-01 2004-05-12 Astrazeneca Ab Novel ligand for nicotinic acetylcholine receptors useful in therapy
PL368045A1 (en) * 2001-07-09 2005-03-21 Combinatorx, Incorporated Combinations for the treatment of inflammatory disorders
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
ES2379544T3 (es) 2001-09-27 2012-04-27 Ramot At Tel Aviv University Ltd. Conjugado de perfenazina y GABA y usos del mismo
EP1499618B1 (en) 2002-04-18 2010-10-13 AstraZeneca AB Furyl compounds
WO2003087103A1 (en) 2002-04-18 2003-10-23 Astrazeneca Ab Thienyl compounds
ES2326638T3 (es) 2002-04-18 2009-10-16 Astrazeneca Ab Compuestos heterociclicos.
SE0202465D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202430D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202598D0 (sv) 2002-09-02 2002-09-02 Astrazeneca Ab Alpha-7 Nicotinic receptor agonists and statins in combination
JP2005539076A (ja) 2002-09-18 2005-12-22 エフ　エム　シー　コーポレーション 殺虫用三環式誘導体
JP2006510697A (ja) * 2002-12-20 2006-03-30 ビーエーエスエフ　アクチェンゲゼルシャフト 殺虫性ジベンゾ（ヘテロ）アゼピン誘導体
CN1741803A (zh) * 2003-01-23 2006-03-01 阿卡蒂亚药品公司 N－脱甲基氯氮平在治疗人神经精神疾病中的用途
CA2516646A1 (en) 2003-02-22 2004-09-10 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
DE10310196A1 (de) 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose
JP2006523707A (ja) 2003-04-15 2006-10-19 アストラゼネカ アクツィエボラーグ 治療化合物
US20060217366A1 (en) * 2003-07-02 2006-09-28 Astrazeneca Ab Method of treating schizophrenia and other disorders
PL195728B1 (pl) 2003-07-18 2007-10-31 Helm Ag Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny
CA2550735A1 (en) 2003-12-22 2005-07-14 Acadia Pharmaceuticals Inc. Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
RU2394030C2 (ru) * 2003-12-22 2010-07-10 Акадиа Фармасьютикалз Инк. АМИНОЗАМЕЩЕННЫЕ АНАЛОГИ ДИАРИЛ [a,d] ЦИКЛОГЕПТЕНА В КАЧЕСТВЕ МУСКАРИНОВЫХ АГОНИСТОВ И СПОСОБЫ ЛЕЧЕНИЯ ПСИХОНЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ
US20060063754A1 (en) * 2004-09-21 2006-03-23 Edgar Dale M Methods of treating a sleep disorder
WO2006071730A1 (en) 2004-12-27 2006-07-06 Astrazeneca Ab Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders
JP2008526839A (ja) * 2005-01-07 2008-07-24 アストラゼネカ・アクチエボラーグ １１−ピペラジン−１−イルジベンゾ［ｂ，ｆ］［１，４］チアゼピン又はその薬学的に許容される塩の新規な使用及び経口医薬組成物への新規な使用
WO2006107948A2 (en) * 2005-04-04 2006-10-12 Acadia Pharmaceuticals Inc. Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
CN101622002A (zh) 2006-12-20 2010-01-06 阿斯利康(瑞典)有限公司 化合物及其用途
CN101605792A (zh) 2007-02-09 2009-12-16 阿斯利康(瑞典)有限公司 氮杂-异吲哚酮和它们作为亲代谢性谷氨酸受体增效剂-613的用途
US7491871B2 (en) 2007-04-25 2009-02-17 Stine Seed Farm, Inc. Soybean cultivar S060299
TW200911255A (en) 2007-06-07 2009-03-16 Astrazeneca Ab Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
TWI417100B (zh) 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
TWI488854B (zh) * 2008-06-20 2015-06-21 Astrazeneca Ab 二苯并噻氮呯衍生物及其用途

Also Published As

Publication number Publication date
NI201000224A (es) 2012-03-19
CY1113845T1 (el) 2016-07-27
EP2307389A4 (en) 2012-04-11
EA201001889A1 (ru) 2011-08-30
IL229560A (en) 2015-07-30
IL210081A (en) 2013-12-31
CN102131791A (zh) 2011-07-20
UY31919A (es) 2010-01-29
ZA201100488B (en) 2011-10-26
US20110160184A1 (en) 2011-06-30
EP2307389B1 (en) 2013-01-23
WO2009154563A1 (en) 2009-12-23
US8158618B2 (en) 2012-04-17
CN102131791B (zh) 2014-12-24
CA2728675A1 (en) 2009-12-23
AU2009260905B2 (en) 2012-08-23
MX2010014203A (es) 2011-02-22
EP2307389A1 (en) 2011-04-13
IL210081A0 (en) 2011-02-28
DOP2010000393A (es) 2011-01-31
AR072200A1 (es) 2010-08-11
ECSP10010698A (es) 2011-01-31
SI2307389T1 (sl) 2013-04-30
NZ590616A (en) 2012-09-28
ES2402084T3 (es) 2013-04-26
TWI488854B (zh) 2015-06-21
HN2010002683A (es) 2013-01-15
KR20110019781A (ko) 2011-02-28
US8653257B2 (en) 2014-02-18
JP2011524898A (ja) 2011-09-08
ME01516B (me) 2014-04-20
CU20100252A7 (es) 2011-11-15
CU23884B1 (es) 2013-04-19
HRP20130234T1 (hr) 2013-04-30
TW201002702A (en) 2010-01-16
PT2307389E (pt) 2013-03-28
RS52703B (sr) 2013-08-30
US20120202991A1 (en) 2012-08-09
CR11860A (es) 2011-02-25
DK2307389T3 (da) 2013-04-02
US20090318415A1 (en) 2009-12-24
CL2010001471A1 (es) 2011-05-06
PL2307389T3 (pl) 2013-05-31
JP2014098006A (ja) 2014-05-29
MY157518A (en) 2016-06-15
BRPI0914231A2 (pt) 2015-11-03
PE20110029A1 (es) 2011-02-11
AU2009260905A1 (en) 2009-12-23
SV2010003769A (es) 2011-05-20
HK1156308A1 (en) 2012-06-08
IL229560A0 (en) 2014-01-30
JP5468068B2 (ja) 2014-04-09

Similar Documents

Publication Publication Date Title
MY157518A (en) Dibenzothiazepine derivatives and use thereof
MX2013005826A (es) Benzoxazepinas como inhibidores de fosfatidilinositol 3-cinasa/objetivo de rapamicina en mamiferos (p13k/mtor) y metodos de uso y fabricacion.
TW200833324A (en) Sulfonamide derivatives
GEP20156216B (en) Heterocyclic compound and usage thereof
UY32192A (es) COMPUESTOS PIRAZOLO[1,5-a]PIRIMIDINA SUSTITUIDA COMO INHIBIDORES DE TRK CINASA
GEP20146102B (en) Compounds and compositions as protein kinase inhibitors
TN2010000131A1 (en) Polo-like kinase inhibitors
MX2009012595A (es) Derivados de espiroindolinona.
TW201129565A (en) Tricyclic heterocyclic compounds, compositions and methods of use thereof
SV2011004004A (es) Composiciones del acido propano-1-sulfonico {3-[5-(4-cloro-fenil)-1h-pirrolo [2,3-b]-piridina-3-carbonil]-2,4-difluoro-fenil}-amida y el uso de las mismas
JO3073B1 (ar) مثبطات ثنائية ملتحمة ثلاثية الحلقة ل cdk 4/6 و flt3
MX2010002341A (es) Derivados de bencimidazol usados como agonistas del receptor x de farnesoide.
MX347562B (es) Derivados fungicidas de 3-fenil[(heterociclilmetoxi)imino]metil}-1 ,2,4-oxadiazol-5(4h)-ona sustituidos en 4.
CR20140216A (es) 5,7-imidazo[1,2-c]pirimidinas sustituidas
PH12013500942A1 (en) Triazolopyridine compounds
MX2009013885A (es) Derivados de quinolina fusionados utiles como moduladores de acido gamma-aminobutirico.
IN2012DN01855A (uk)
WO2012071509A3 (en) Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
MX2009007260A (es) Derivados de imidazol como inhibidores de proteina de huso de cinesina (eg-5).
TW200745032A (en) Novel heterobicyclic derivatives
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
UA97256C2 (uk) Заміщені піразоли та триазоли як інгібітори кбв (кінезин-білок веретена)
GEP20135913B (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereat treatment of diseases based on mcp-1 and cx3cr1 expression
MX2011008360A (es) Derivados de piridazinona sustituida con heteroarilo.
IN2012DN01232A (uk)